Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,397 | -14,871 | -7,106 | -9,986 | -5,191 |
| Depreciation Amortization | N/A | N/A | N/A | 6 | 3 |
| Accounts receivable | -931 | -432 | -998 | 372 | -8,834 |
| Accounts payable and accrued liabilities | -1,319 | -1,519 | -89 | 1,082 | 709 |
| Other Working Capital | 1,680 | 62 | 395 | 4,076 | -4,576 |
| Other Operating Activity | 4,829 | 3,752 | 2,082 | 3,338 | 12,229 |
| Operating Cash Flow | $-18,138 | $-13,008 | $-5,716 | $-1,112 | $-5,660 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,497 | 4,041 | 2,479 | 8,979 | 5,482 |
| Common Stock Repurchased | -42 | -42 | -42 | N/A | N/A |
| Other Financing Activity | -186 | -83 | -61 | 0 | -106 |
| Financing Cash Flow | $4,269 | $3,916 | $2,376 | $8,979 | $5,376 |
| Beginning Cash Position | 50,501 | 50,501 | 50,501 | 42,634 | 42,634 |
| End Cash Position | 36,632 | 41,409 | 47,161 | 50,501 | 42,350 |
| Net Cash Flow | $-13,869 | $-9,092 | $-3,340 | $7,867 | $-284 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,138 | -13,008 | -5,716 | -1,112 | -5,660 |
| Free Cash Flow | -18,138 | -13,008 | -5,716 | -1,112 | -5,660 |